TWI800754B - Combination of gene marker and use thereof - Google Patents

Combination of gene marker and use thereof Download PDF

Info

Publication number
TWI800754B
TWI800754B TW109134190A TW109134190A TWI800754B TW I800754 B TWI800754 B TW I800754B TW 109134190 A TW109134190 A TW 109134190A TW 109134190 A TW109134190 A TW 109134190A TW I800754 B TWI800754 B TW I800754B
Authority
TW
Taiwan
Prior art keywords
combination
gene marker
marker
gene
Prior art date
Application number
TW109134190A
Other languages
Chinese (zh)
Other versions
TW202146663A (en
Inventor
李仕良
吳孝林
吳幽治
陳新周
張志偉
肖麗雯
鄒鴻志
Original Assignee
大陸商廣州康立明生物科技股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 大陸商廣州康立明生物科技股份有限公司 filed Critical 大陸商廣州康立明生物科技股份有限公司
Publication of TW202146663A publication Critical patent/TW202146663A/en
Application granted granted Critical
Publication of TWI800754B publication Critical patent/TWI800754B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
TW109134190A 2020-06-03 2020-09-30 Combination of gene marker and use thereof TWI800754B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202010494278.4A CN111705130B (en) 2020-06-03 2020-06-03 Gene marker combination and application thereof
CN202010494278.4 2020-06-03

Publications (2)

Publication Number Publication Date
TW202146663A TW202146663A (en) 2021-12-16
TWI800754B true TWI800754B (en) 2023-05-01

Family

ID=72538593

Family Applications (1)

Application Number Title Priority Date Filing Date
TW109134190A TWI800754B (en) 2020-06-03 2020-09-30 Combination of gene marker and use thereof

Country Status (3)

Country Link
CN (1) CN111705130B (en)
TW (1) TWI800754B (en)
WO (1) WO2021243906A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111705130B (en) * 2020-06-03 2022-07-12 广州康立明生物科技股份有限公司 Gene marker combination and application thereof
CN111662980A (en) * 2020-06-03 2020-09-15 广州市康立明生物科技有限责任公司 Lung cancer detection reagent and kit
CN111647657B (en) * 2020-06-03 2022-07-12 广州康立明生物科技股份有限公司 Lung cancer detection reagent and kit

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106232833A (en) * 2014-01-30 2016-12-14 加利福尼亚大学董事会 The haplotyping that methylates (MONOD) for non-invasive diagnostic

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011091270A2 (en) * 2010-01-21 2011-07-28 The Regents Of The University Of Michigan Biomarkers for lung disease monitoring
CN103627814B (en) * 2013-12-13 2015-05-27 青岛大学医学院附属医院 Reagent for detecting Notch signal path as well as PCR (Polymerase Chain Reaction) detecting method and application thereof
JP6395131B2 (en) * 2014-07-10 2018-09-26 シスメックス株式会社 Method for acquiring information on lung cancer, and marker and kit for acquiring information on lung cancer
WO2016069461A1 (en) * 2014-10-27 2016-05-06 The Trustees Of The University Of Pennsylvania A parkinson's disease diagnostic biomarker panel
US11260387B2 (en) * 2016-12-12 2022-03-01 Cepheid Integrated purification and measurement of DNA methylation and co-measurement of mutations and/or mRNA expression levels in an automated reaction cartridge
CN110964810B (en) * 2018-09-29 2022-04-29 广州康立明生物科技股份有限公司 Application of HOXA7 and HOXA9 methylation detection reagent in preparation of lung cancer diagnostic reagent
CN110964809B (en) * 2018-09-29 2021-10-22 广州康立明生物科技股份有限公司 HOXA7 methylation detection reagent
CN110964813B (en) * 2018-09-29 2021-11-16 广州康立明生物科技股份有限公司 Application of HOXA7 methylation detection reagent in preparation of lung cancer diagnosis reagent
CN110964812B (en) * 2018-09-29 2021-10-22 广州康立明生物科技股份有限公司 Application of HOXA9 methylation detection reagent in preparation of lung cancer diagnosis reagent
CN110317875B (en) * 2019-07-30 2024-06-21 苏州呼呼健康科技有限公司 Methylation gene related to lung cancer and detection kit thereof
CN111705130B (en) * 2020-06-03 2022-07-12 广州康立明生物科技股份有限公司 Gene marker combination and application thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106232833A (en) * 2014-01-30 2016-12-14 加利福尼亚大学董事会 The haplotyping that methylates (MONOD) for non-invasive diagnostic

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
期刊 Daugaard, Iben, et al. "Identification and validation of candidate epigenetic biomarkers in lung adenocarcinoma." Scientific reports 6.1 (2016) , p 1-11.
期刊 O’Mara, Tracy A., et al. "Analysis of promoter-associated chromatin interactions reveals biologically relevant candidate target genes at endometrial cancer risk loci." Cancers 11, 1440 2019 p 1-14.;期刊 Daugaard, Iben, et al. "Identification and validation of candidate epigenetic biomarkers in lung adenocarcinoma." Scientific reports 6.1 (2016) , p 1-11. *

Also Published As

Publication number Publication date
CN111705130A (en) 2020-09-25
CN111705130B (en) 2022-07-12
TW202146663A (en) 2021-12-16
WO2021243906A1 (en) 2021-12-09

Similar Documents

Publication Publication Date Title
TWI800754B (en) Combination of gene marker and use thereof
EP4022059A4 (en) Oligonucleotide compositions and methods of use thereof
EP3959318A4 (en) Oligonucleotide compositions and methods of use thereof
EP3965780A4 (en) Oligonucleotide compositions and methods of use thereof
EP4037695A4 (en) Oligonucleotide compositions and methods of use thereof
EP3775203A4 (en) Oligonucleotide compositions and methods of use thereof
EP4143196A4 (en) PI3K-a INHIBITORS AND METHODS OF USE THEREOF
EP4045643A4 (en) Variants of cas12a nucleases and methods of making and use thereof
EP3962479A4 (en) Kcnt1 inhibitors and methods of use
EP3983386A4 (en) Acss2 inhibitors and methods of use thereof
EP3962481A4 (en) Kcnt1 inhibitors and methods of use
EP3941475A4 (en) Pyridazinones and methods of use thereof
EP3986894A4 (en) Ectonucleotidase inhibitors and methods of use thereof
EP3998354A4 (en) Genetic marker combination and application thereof
EP4090752A4 (en) Plakophillin-2 gene therapy methods and compositions
EP4039676A4 (en) Compound for inducing expression of anti-aging gene klotho and use thereof
EP4081231A4 (en) Compositions comprising microbes and methods of use and making thereof
EP4048298A4 (en) Preparation and use of therapeutic hydrogels
EP3941515A4 (en) Targeted active gene editing agent and methods of use
EP3816282A4 (en) Enzymes of luciferin biosynthesis and use thereof
EP3909063A4 (en) Multiplexed assay and methods of use thereof
EP4037715A4 (en) Protein-macromolecule conjugates and methods of use thereof
EP4142740A4 (en) Compositions and methods of use thereof
EP3959197A4 (en) Papd5 inhibitors and methods of use thereof
EP3950961A4 (en) Application of kdm5a gene and atrx gene